.
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.over the years, i�ve talked to reporters who are solidly addicted to obfuscations. like any addict, they have an army of excuses to rationalize their behavior.
.
according to fema, the federal emergency management agency, there were 195 fires and explosions involving electronic cigarettes between 2009 and 2016 in the united states.
.